Cerebrotendinous Xanthomatosis: A Literature Review and Case Study
Author Information
Author(s): Matta Anthony, Ory Magne Fabienne, Levade Thierry, Bonneville Fabrice, Ferrières Jean
Primary Institution: Toulouse University Hospital, Toulouse, France
Hypothesis
Is early diagnosis essential to improve patient outcomes in cerebrotendinous xanthomatosis?
Conclusion
Cerebrotendinous xanthomatosis is a rare but treatable metabolic disorder, and early diagnosis is crucial for effective management.
Supporting Evidence
- Cerebrotendinous xanthomatosis can lead to severe neurological issues if untreated.
- Chenodeoxycholic acid is an effective treatment for managing the disorder.
- Early diagnosis can significantly improve patient outcomes.
Takeaway
Cerebrotendinous xanthomatosis is a rare disease that can cause serious health problems, but if doctors catch it early, they can help patients feel better with the right medicine.
Methodology
This review includes a literature review and a case study of a patient diagnosed with cerebrotendinous xanthomatosis.
Potential Biases
Potential bias in diagnosis due to the rarity and complexity of the disease.
Limitations
The study is based on a single case report, which may not be generalizable to all patients with cerebrotendinous xanthomatosis.
Participant Demographics
A 49-year-old woman with a history of tendon xanthomas and cardiovascular issues.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website